Pharvaris director proposes sale of 11,969 shares
The notice links the planned sale to option exercises under a registered plan and identifies cash as the payment method.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Pharvaris N.V. Director Viviane Rosine Francoise Beck Monges reported a proposed sale of 11,969 Common shares, with an aggregate market value of $395,523.98 and an approximate sale date of September 23, 2026. The shares are listed as acquired from the issuer through exercise of options under a registered plan, with cash shown as the payment method. Morgan Stanley Smith Barney LLC Executive Financial Services is listed as broker.
Key Figures
Key Terms
Rule 144 regulatory
Exercise of Options Under a Registered Plan financial
registered plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.